title: Sexual dimorphism in the renin-angiotensin system in aging spontaneously hypertensive rats.
abstract: In young adult spontaneously hypertensive rats (SHR), mean arterial pressure (MAP) is higher in males than in females and inhibition of the renin-angiotensin system (RAS) eliminates this sex difference. After cessation of estrous cycling in female SHR, MAP is similar to that in male SHR. The purpose of this study was to determine the role of the RAS in maintenance of hypertension in aging male and female SHR. At 16 mo of age, MAP was similar in male and female SHR (183+/-5 vs. 193+/-8 mmHg), and chronic losartan (40 mg.kg-1.day-1 po for 3 wk) reduced MAP by 52% (to 90+/-8 mmHg, P<0.05 vs. control) in males and 37% (to 123+/-11 mmHg, P<0.05 vs. control) in females (P<0.05, females vs. males). The effect of losartan on angiotensin type 1 (AT1) receptor blockade was similar: MAP responses to acute doses of ANG II (62.5-250 ng/kg) were blocked to a similar extent in losartan-treated males and females. F2-isoprostane excretion was reduced with losartan more in males than in females. There were no sex differences in plasma renin activity, plasma angiotensinogen or ANG II, or renal expression of AT1 receptors, angiotensin-converting enzyme, or renin. However, renal angiotensinogen mRNA and protein expression was higher in old males than females, whereas renal ANG II was higher in old females than males. The data show that, in aging SHR, when blood pressures are similar, there remains a sexual dimorphism in the response to AT1 receptor antagonism, and the differences may involve sex differences in mechanisms responsible for oxidative stress with aging.
authors.affiliation: Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 N. State St., Jackson, MS 39216-4505, USA.
authors.forename: Licy L
authors.initials: LL
authors.lastname: Yanes
authors.forename: Damian G
authors.initials: DG
authors.lastname: Romero
authors.forename: Joshua W
authors.initials: JW
authors.lastname: Iles
authors.forename: Radu
authors.initials: R
authors.lastname: Iliescu
authors.forename: Celso
authors.initials: C
authors.lastname: Gomez-Sanchez
authors.forename: Jane F
authors.initials: JF
authors.lastname: Reckelhoff
mesh_terms: D000317:Adrenergic alpha-Antagonists; D000375:Aging / Q000187:drug effects*; D000809:Angiotensins / Q000378:metabolism*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D005260:Female; D007668:Kidney / Q000378:metabolism; D019808:Losartan / Q000494:pharmacology; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects; D051381:Rats; D011918:Rats, Inbred SHR; D012084:Renin-Angiotensin System / Q000502:physiology*; D012727:Sex Characteristics
chemical_list: D000317:Adrenergic alpha-Antagonists; D000809:Angiotensins; D000959:Antihypertensive Agents; D019808:Losartan